Big Biotech companies are demonstrating they are better positioned than their pharmaceutical industry counterparts to meet changing demands, according to an analysis by Burrill & Company. Big Biotech has outpaced Big Pharma in terms of growth of sales, income, investment in R&D, and market cap during the past three years, the financial services company reports.

Embedded Link

Big Biotech Outpaces Big Pharma, Burrill Reports – – BioPharm International
Big Biotech companies are demonstrating they are better positioned than their pharmaceutical industry counterparts to meet changing demands.

Google+: View post on Google+

Tags:

Comments are closed.